Phathom Pharmaceuticals Inc (PHAT) Stock Price, Quote, News & History

PHATNASDAQ
$12.88
-0.59-4.38%
At close: Apr 20, 5:00 PM EST
$12.95
-0.52-3.87%
Pre-Market: 3:00 AM EST
Earnings: Q1 2026 Earnings in 8 days from now on Thu Apr 30th, before the market open

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-166.78M
Investing Cash Flow (TTM)
-229.00K
Financing Cash Flow (TTM)
-288.00K
Free Cash Flow (TTM)
-167.00M
Capital Expenditure (TTM)
-229.00K
Net Change in Cash (TTM)
-167.29M

Analyst Trends and Forecast

1
Oct 25
1
Dec 25
1
Feb
1
Mar
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
3.9
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$1.11B
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
5.37
PB Ratio (TTM)
-
Earnings Yield % (TTM)
-23.51%
Earnings Yield % (FWD)
-2.25%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
-$5.52

Company Debt

Total Debt
$209.09M
LT Debt
$209.09M
LT Debt Issuance (TTM)
$0
LT Debt Repayment (TTM)
-
Total Cash
$129.97M
Debt to Equity
-
Issuance of Debt (TTM)
$0
Repayment of Debt (TTM)
-

Key Statistics

Open
-
Close
$12.88
Volume / Avg.
0 / 1.05M
Day Range
- - -
52 Wk Range
2.21 - 18.31
Market Cap
$1.01B
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
53
Short Interest
21.26%
Days to Cover
9.23

About

Sector
Health Care
Industry
Pharmaceuticals
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Phathom Pharmaceuticals (PHAT) stock?

A

You can purchase shares of Phathom Pharmaceuticals (NASDAQ:PHAT) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Phathom Pharmaceuticals (PHAT) competitors?

Q

What is the forecast, or price target, for Phathom Pharmaceuticals (PHAT) stock?

A

Phathom Pharmaceuticals has a consensus price target of $20.43.

Q

What is the current price for Phathom Pharmaceuticals (PHAT)?

A

The stock price for Phathom Pharmaceuticals (NASDAQ: PHAT) is $12.9489 last updated April 21, 2026 at 7:16 PM EDT.

Q

Does Phathom Pharmaceuticals (PHAT) pay a dividend?

A

There are no upcoming dividends for Phathom Pharmaceuticals.

Q

When is Phathom Pharmaceuticals (NASDAQ:PHAT) reporting earnings?

A

Phathom Pharmaceuticals does not have any upcoming earnings scheduled.

Q

Is Phathom Pharmaceuticals (PHAT) going to split?

A

There is no upcoming split for Phathom Pharmaceuticals.

Q

What sector and industry does Phathom Pharmaceuticals (PHAT) operate in?

A

Phathom Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.